Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study

Abstract Background The burden of chronic obstructive lung disease (COPD) is increasing in women, with recent evidence suggesting gender differences in disease characteristics and potentially in treatment outcomes. Methods FLAME was a 52-week randomized controlled trial in patients with severe-to-ve...

Full description

Bibliographic Details
Main Authors: Jadwiga A. Wedzicha, Dave Singh, Ioanna Tsiligianni, Christine Jenkins, Sebastian Fucile, Robert Fogel, Steven Shen, Pankaj Goyal, Karen Mezzi, Konstantinos Kostikas
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Respiratory Research
Subjects:
Chronic obstructive pulmonary disease
Gender
Indacaterol/glycopyrronium
Exacerbation reduction
Lung function
Online Access:http://link.springer.com/article/10.1186/s12931-019-0972-7

Internet

http://link.springer.com/article/10.1186/s12931-019-0972-7

Similar Items